A collagen-binding protein enables molecular imaging of kidney fibrosis in vivo.
chronic kidney disease (CKD)
collagen
extracellular matrix
molecular imaging
non-invasive imaging
renal fibrosis
Journal
Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
received:
21
05
2019
revised:
02
08
2019
accepted:
22
08
2019
pubmed:
1
12
2019
medline:
22
6
2021
entrez:
1
12
2019
Statut:
ppublish
Résumé
Pathological deposition of collagen is a hallmark of kidney fibrosis. To illustrate this process we employed multimodal optical imaging to visualize and quantify collagen deposition in murine models of kidney fibrosis (ischemia-reperfusion or unilateral ureteral obstruction) using the collagen-binding adhesion protein CNA35. For in vivo imaging, we used hybrid computed tomography-fluorescence molecular tomography and CNA35 labeled with the near-infrared fluorophore Cy7. Upon intravenous injection, CNA35-Cy7 accumulation was significantly higher in fibrotic compared to non-fibrotic kidneys. This difference was not detected for a non-specific scrambled version of CNA35-Cy7. Ex vivo, on kidney sections of mice and patients with renal fibrosis, CNA35-FITC co-localized with fibrotic collagen type I and III, but not with the basement membrane collagen type IV. Following intravenous injection, CNA35-FITC bound to both interstitial and perivascular fibrotic areas. In line with this perivascular accumulation, we observed significant perivascular fibrosis in the mouse models and in biopsy sections from patients with chronic kidney disease using computer-based morphometry quantification. Thus, molecular imaging of collagen using CNA35 enabled specific non-invasive quantification of kidney fibrosis. Collagen imaging revealed significant perivascular fibrosis as a consistent component next to the more commonly assessed interstitial fibrosis. Our results lay the basis for further probe and protocol optimization towards the clinical translation of molecular imaging of kidney fibrosis.
Identifiants
pubmed: 31784048
pii: S0085-2538(19)30919-6
doi: 10.1016/j.kint.2019.08.029
pmc: PMC7115881
mid: EMS86769
pii:
doi:
Substances chimiques
Carrier Proteins
0
Collagen
9007-34-5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
609-614Subventions
Organisme : European Research Council
ID : 813086
Pays : International
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2019 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
Références
Theranostics. 2016 Jan 01;6(3):328-41
pubmed: 26909109
Mol Aspects Med. 2019 Feb;65:16-36
pubmed: 29909119
ACS Nano. 2013 Jan 22;7(1):252-62
pubmed: 23067565
Anal Biochem. 2006 Mar 15;350(2):177-85
pubmed: 16476406
PLoS One. 2011 Apr 20;6(4):e19097
pubmed: 21533060
Adv Drug Deliv Rev. 2017 Nov 1;121:9-26
pubmed: 29108860
J Vis Exp. 2015 Jun 04;(100):e52770
pubmed: 26066033
Cell Stem Cell. 2016 Nov 3;19(5):628-642
pubmed: 27618218
Sci Transl Med. 2017 Apr 5;9(384):
pubmed: 28381537
J Struct Biol. 2007 Sep;159(3):392-9
pubmed: 17572104
Sci Transl Med. 2019 Apr 3;11(486):
pubmed: 30944168
Adv Chronic Kidney Dis. 2017 Mar;24(2):117-129
pubmed: 28284377
Cell Stem Cell. 2015 Jan 8;16(1):51-66
pubmed: 25465115
J Am Chem Soc. 2019 Apr 10;141(14):5593-5596
pubmed: 30908032